Overexpression of Interleukin-33 in Recombinant Rabies Virus Enhances Innate and Humoral Immune Responses through Activation of Dendritic Cell-Germinal Center Reactions
Open Access
Abstract
Rabies is a zoonotic infectious disease caused by rabies virus (RABV), and its mortality rate is as high as 100%. Globally, an average of 60,000 people die from rabies each year. The most effective method to prevent and limit rabies is vaccination, but it is currently expensive and inefficient, consisting of a 3-dose series of injections and requiring to be immunized annually. Therefore, it is urgent to develop a single dose of long-acting rabies vaccine. In this study, recombinant rabies virus (rRABV) overexpressing interleukin-33 (IL-33) was constructed and designated as rLBNSE-IL33, and its effect was evaluated in a mouse model. The results showed that rLBNSE-IL33 could enhance the quick production of RABV-induced immune antibodies as early as three days post immunization (dpi) through the activation of dendritic cells (DCs), a component of the innate immune system. Furthermore, rLBNSE-IL33 induced high-level virus-neutralizing antibodies (VNA) production that persisted for 8 weeks by regulating the T cell-dependent germinal center (GC) reaction, thus resulting in better protection against rabies. Our data suggest the IL-33 is a novel adjuvant that could be used to enhance innate and humoral immune responses by activating the DC-GC reaction, and thus, rLBNSE-IL33 could be developed as a safe and effective vaccine for animals.Keywords
Funding Information
- National Natural Science Foundation of China (31960702, 31522057, 31872451)
- Li Yunqing expert workstation, YunNan (No.202005AF150014)
- Innovation Team of Neurobiology, Dali University (NO. ZKLX2019108)
- Key Laboratory of Medical Molecular Diagnosis in Colleges and Universities of Yunnan Province (NO 36)
This publication has 44 references indexed in Scilit:
- IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin GProceedings of the National Academy of Sciences, 2012
- Cutting Edge: Dendritic Cell-Restricted Antigen Presentation Initiates the Follicular Helper T Cell Program but Cannot Complete Ultimate Effector DifferentiationThe Journal of Immunology, 2011
- Human lymph node development: An inflammatory interactionImmunology Letters, 2011
- B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cellsJournal of Experimental Medicine, 2011
- Follicular Helper CD4 T Cells (TFH)Annual Review of Immunology, 2011
- Expression of MIP-1α (CCL3) by a Recombinant Rabies Virus Enhances Its Immunogenicity by Inducing Innate Immunity and Recruiting Dendritic Cells and B CellsJournal of Virology, 2010
- T cells and follicular dendritic cells in germinal center B‐cell formation and selectionImmunological Reviews, 2010
- T Follicular Helper (TFH) Cells in Normal and Dysregulated Immune ResponsesAnnual Review of Immunology, 2008
- NK cells interactions with dendritic cells shape innate and adaptive immunityFrontiers in Bioscience-Landmark, 2008
- Dominance of a Nonpathogenic Glycoprotein Gene over a Pathogenic Glycoprotein Gene in Rabies VirusJournal of Virology, 2007